ORIGINAL RESEARCH article
Front. Sports Act. Living
Sec. Women in Sport
Volume 7 - 2025 | doi: 10.3389/fspor.2025.1665482
This article is part of the Research TopicBridging the Knowledge Gap: Enhancing Research on Women's Participation in SportsView all 9 articles
Menstruation and injury occurrence; a four season observational study in elite female football players
Provisionally accepted- 1Sant Joan de Déu Hospital, Barcelona, Spain
- 2Barca Innovation Hub, Barcelona, Spain
- 3Universitat de Barcelona, Barcelona, Spain
- 4University College London Division of Medicine, London, United Kingdom
- 5Instituto de Salud Global de Barcelona, Barcelona, Spain
- 6FC Barcelona Servicios Medicos, Barcelona, Spain
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
BACKGROUD The menstrual cycle (MC) has been proposed as a factor influencing injury risk in female athletes due to hormonal effects on musculoskeletal, metabolic, and neuromuscular systems. However, inconsistencies in study methods and variability in defining menstrual phases have produced conflicting findings. The absence of biological hormone measurements often forces reliance on estimations, limiting data accuracy. Each menstrual phase has distinct hormonal profiles, yet menstruation remains the only stage where hormone status can be inferred with certainty, as it is characterized by low ovarian hormone levels. Understanding this relationship in elite female football players is important for optimizing training load, recovery, health management, and injury prevention. OBJECTIVE To examine whether the early follicular phase (menstruation) is associated with musculoskeletal time-loss injuries in elite female football players across four competitive seasons. STUDY DESIGN Descriptive epidemiological study. METHODS Thirty-three elite female football players were prospectively monitored between the 2019/20 and 2022/23 seasons. Menstrual cycle data were tracked using a calendar-based digital tool, while injuries were classified using the OSICS-10 coding system. Incidence rates per 1,000 hours of exposure were compared between menstruation (bleeding) and non-bleeding phases. In this study, “bleeding,” “menstruation,” “phase 1,” and “early follicular phase” are used interchangeably. RESULTS A total of 852 menstrual cycles and 80 injuries were recorded. 77.5%, occurred in training while 22.5% were during matches. Muscle injuries accounted for 57.5% of cases, ligament injuries 30%, and tendon injuries 12.5%. Injuries during menstruation represented 13.7% of all cases. The overall injury incidence was 6.42 per 1,000 hours (95% CI: 5.09–7.99), with 5.46 during menstruation and 6.60 during non-bleeding phases (p = 0.55). Although rates did not differ significantly, the injury burden was markedly higher during menstruation (684 vs. 206 days lost per 1,000 hours; p = 0.0027), indicating greater severity. CONCLUSIONS Injury incidence did not differ significantly between menstrual phases; however, injuries sustained during menstruation were more severe, resulting in a substantially higher burden. These findings underscore the value of individualized menstrual tracking to support injury prevention and athlete health strategies. Further studies using direct hormonal measurements are warranted to validate and extend these results.
Keywords: female football, Hormones, Menstrual Cycle, muscleskeletal injuries, calendar based
Received: 14 Jul 2025; Accepted: 21 Oct 2025.
Copyright: © 2025 Ferrer, Keay, Balagué-Dobón, Caceres, Jarrin, Rodas and Gonzalez Ruiz. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Eva Ferrer, docbcn@yahoo.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.